🇺🇸 Galantamine oral solution in United States

FDA authorised Galantamine oral solution on 28 February 2001

Marketing authorisations

FDA — authorised 28 February 2001

  • Application: NDA021169
  • Marketing authorisation holder: JANSSEN PHARMS
  • Local brand name: RAZADYNE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Galantamine oral solution in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Galantamine oral solution approved in United States?

Yes. FDA authorised it on 28 February 2001; FDA has authorised it.

Who is the marketing authorisation holder for Galantamine oral solution in United States?

JANSSEN PHARMS holds the US marketing authorisation.